Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN04
- Pharmacological subgroupN04B
- Chemical subgroupN04BD
- Chemical substanceN04BD02Rasagiline
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Health Canada · 14 medicines
CBG-MEB · 10 medicines
MS · 10 medicines · Historical list
HALMED · 9 medicines
Anvisa · 8 medicines
ALIMS · 7 medicines
EMA · 3 medicines
FDA · 2 medicines
PHARMAC · 1 medicine
SFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
129 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rasagiline Mesylate | United States | 0.5MG BASE, 1MG BASE | tablet | Marketed | Watson Labs INC |
| Rasagiline ratiopharm | European Union | Authorised | Teva B.V. | ||
| Rasagiline CF 1 mg, tabletten | Netherlands | Tablet | Authorised | Centrafarm B.V. | |
| Rasagiline Viatris (previously Rasagiline Mylan) | European Union | Authorised | Viatris Limited | ||
| Rasagiline Krka 1 mg tabletten | Netherlands | Tablet | Authorised | Krka d.d., Novo mesto | |
| Rasagiline ratiopharm 1 mg, tablet | Netherlands | Tablet | Authorised | Teva Pharma B.V. | |
| Rasagiline Sandoz 1 mg, tabletten | Netherlands | Tablet | Authorised | Sandoz B.V. | |
| Rasagiline Synthon 1 mg, tabletten | Netherlands | Tablet | Authorised | Synthon B.V. | |
| Rasagiline Viatris 1 mg, tabletten | Netherlands | Tablet | Authorised | Viatris Limited | |
| Rasagiline Aurobindo 1 mg, tabletten | Netherlands | Tablet | Authorised | Aurobindo Pharma B.V. | |
| Rasagiline BioOrganics 1 mg, tabletten | Netherlands | Tablet | Authorised | BioOrganics BV | |
| Rasagiline DOC Generici 1 mg, tabletten | Netherlands | Tablet | Authorised | DOC Generici S.r.l. | |
| AG-Rasagiline | Canada | 1 MG | Tablet | Authorised | Angita Pharma INC. |
| AG-Rasagiline | Canada | 0.5 MG | Tablet | Authorised | Angita Pharma INC. |
| Apo-Rasagiline | Canada | 1 MG | Tablet | Marketed | Apotex INC |
| Apo-Rasagiline | Canada | 0.5 MG | Tablet | Marketed | Apotex INC |
| Jamp Rasagiline | Canada | 0.5 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Jamp Rasagiline | Canada | 1 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Teva-Rasagiline | Canada | 0.5 MG | Tablet | Marketed | Teva Canada Limited |
| Teva-Rasagiline | Canada | 1 MG | Tablet | Marketed | Teva Canada Limited |
| Asn-Rasagiline | Canada | 0.5 MG | Tablet | Authorised | Ascend Laboratories LTD |
| Asn-Rasagiline | Canada | 1 MG | Tablet | Authorised | Ascend Laboratories LTD |
| Mint-Rasagiline | Canada | 0.5 MG | Tablet | Authorised | Mint Pharmaceuticals INC |
| Mint-Rasagiline | Canada | 1 MG | Tablet | Authorised | Mint Pharmaceuticals INC |
| Azilect | United States | 0.5MG BASE, 1MG BASE | tablet | Marketed | Teva |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.